Medicare Drug Price Negotiations Will Have Domino Effect for Community Oncology Practices

The 340B Drug Pricing Program was enacted by Congress in 1992 and has become the second largest federally sponsored drug program in the U.S. only surpassed by Medicare Part D.

In 2021, Jessica Sheth Bhutada, MD, MS, and colleagues uncovered a startling 2% annual uptick in metastatic stomach cancer in young adults, despite declining rates in older adults. Three years later, they are still trying to understand why.

Oral cannabis extract could be an effective adjunct to standard antiemetic prophylaxis for patients with chemotherapy-induced nausea and vomiting (CINV), according to the results of a first-of-its-kind phase 2/3 study published in the Journal of Clinical Oncology.

For patients with kidney cancer, understanding how palliative care can help is essential throughout the treatment process.